Retirees open up about their finances and how they spend their time.

Yahoo Finance shook things up this year, not just naming a Company of the Year but also Surprise of the Year, Product of the Year, and Comeback of the Year. Walmart (WMT) was named Yahoo Finance's 2024 Comeback of the Year on the strength of its stock and earnings performance. Yahoo Finance Executive Editor Brian Sozzi spoke with CEO Doug McMillon about how the retailer's big investments have been paying off, while CFO John David Rainey explained that the company's recent success didn't happen by accident. Yahoo Finance's Surprise of the Year was General Motors (GM). CEO Mary Barra credits the automaker's diverse portfolio for its big success. Bank of America auto analyst John Murphy also weighed in to give his take on what could be next for the stock. Nvidia's (NVDA) AI-focused Blackwell platform was named Product of the Year. Comeback of the Year went to Robinhood (HOOD). Its stock has surged and it made big headway in diversifying its product offerings. CEO Vlad Tenev discusses what's next for the company while Mizuho senior analyst Dan Dolev argues Robinhood is a stock to own under the incoming Trump administration. Watch more Yahoo Finance Awards coverage here: Why Walmart is clobbering its rivals Walmart rolled back DEI efforts & others may too. Here's why. The 'exciting' part of Robinhood's growth is still ahead: Analyst

Low-end legacy chips not subject to restrictions but vital to industry have given strength to Chinese manufacturers.

Friday’s gains help, but don’t reverse, weekly declines by major indexes; Nike says it expects lower sales and margins this fiscal quarter.

Friday’s gains help, but don’t reverse, weekly declines by major indexes; Nike says it expects lower sales and margins this fiscal quarter.

The move follows an earlier Wall Street Journal investigation that revealed a toxic and sexualized workplace culture at the bank regulator.

The article, since removed, featured a key CoinDesk sponsor and a $6 million banana.

Unprecedented extreme weather boosted prices of cocoa, coffee and orange juice to new records in 2024 — and they’re showing signs of going even higher in 2025.

Simplifying cryptocurrency systems is key to widespread adoption, emphasizing user-centric innovation and intuitive design.

DSB selects Motorola Solutions' TETRA radio solutions to bolster mission-critical communication throughout the country.

Eli Lilly is now comfortably ahead of Novo Nordisk in the race to dominate the market for obesity treatments.

Small-time investors may soon gain easier access to so-called private markets. That usually means higher fees, greater risk, more conflicts of interest and a harder time selling.

Brent crude is expected to average $71.57 a barrel next year, while West Texas Intermediate is seen at $67.44 a barrel. Global oil demand growth slowed significantly this year.

Q4 earnings season is still a few weeks away, with several IBD 50 firms, including Palantir stock, still in major growth mode.

The bitcoin price, after soaring on Trump euphoria, has gone into reverse as Treasury yields jumped following Wednesday's Fed meeting.

We recently compiled a list of the 10 Best Telecom Dividend Stocks To Buy for 2024. In this article, we are going to take a look at where Motorola Solutions, Inc. (NYSE:MSI) stands against the other telecom dividend stocks. The telecommunications sector plays a vital role in the United States, attracting considerable interest from investors due […]

We recently published a list of 12 Crypto Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Robinhood Markets, Inc. (NASDAQ:HOOD) stands against other crypto stocks with the biggest upside potential. Bitcoin Continues Its All-Time Highs On December 16, Bitcoin reached another all-time high, soaring above […]

Asset managers hoping to seize on the momentum of bitcoin funds are jockeying to put smaller tokens into exchange-traded funds.

The UnitedHealthcare CEO shooting has sharpened the public’s focus on the role of private insurers, a necessary evil in the U.S. healthcare system.